阿托伐他汀联合丹参酮ⅡA磺酸钠注射液对冠心病患者心绞痛影响OACSTPCD
Atorvastatin Combined with Danshen Ketone ⅡA Sulfonic Acid Sodium Injection in the Treatment of Angina Pectoris of Coronary Heart Disease
目的：：观察阿托伐他汀联合丹参酮ⅡA 磺酸钠注射液治疗冠心病心绞痛疗效,探讨其临床价值。方法：选择本院于2014年3月至2015年9月收治的92例患者作为研究对象,按照配对分组法分为两组,每组46例,对照组给予阿托伐他汀治疗,观察组给予阿托伐他汀联合丹参酮ⅡA 磺酸钠注射液治疗,比较两组疗效。结果：观察组治疗总有效率为44例(95.7％),高于对照组35例(76.1％),差异具有统计学意义(P <0.05)。观察组心电图疗效总有效率为43例…查看全部>>
Objective: To observe the effect of atorvastatin combined with Danshen ketone II A sulfonic acid sodium injection in the treatment of angina pectoris of coronary heart disease, and to explore its clinical value. Methods: 92 patients treated in our hospital from March 2014 to September 2015 were divided into two groups, with 46 cases in each group, the control group was treated with atorvastatin, the observation group was treated with atorvastatin combined wi…查看全部>>
夏世杰;尹扬光;方颖
重庆市职业病防治 院，重庆 南岸区 400060重庆市职业病防治 院，重庆 南岸区 400060贵阳医学院附属医院心血管内科，贵州贵阳 550000
阿托伐他汀丹参酮ⅡA磺酸钠注射液冠心病心绞痛
AtorvastatinDanshen ketone IIA sulfonic acid sodium injectionCoronary heart dis-easeAngina pectoris
《河北医学》 2016 (7)
1067-1070,4
重庆市医学科研计划项目,(编号:2012－2.377)
评论